SALVAGE CHEMOTHERAPY WITH BEVACIZUMAB-IRINOTECAN ASSOCIATION IN RECURRENT/REFRACTORY BRAIN TUMORS IN CHILDREN

被引：0
|
作者：
Schiavetti, A. [1 ]
Varrasso, G. [1 ]
Reale, G. [1 ]
De Grazia, A. [1 ]
Ferrara, E. [1 ]
Paiano, M. [1 ]
Clerico, A. [1 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-145
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [21] SALVAGE CHEMOTHERAPY WITH PACLITAXEL FOR RECURRENT PRIMARY BRAIN-TUMORS
    CHAMBERLAIN, MC
    KORMANIK, P
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 2066 - 2071
  • [22] Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors
    Okada, Keiko
    Yamasaki, Kai
    Tanaka, Chika
    Fujisaki, Hiroyuki
    Osugi, Yuko
    Hara, Junichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) : 1073 - 1079
  • [23] Bevacizumab plus irinotecan in treatment of recurrent brain gliomas
    Stec, Rafal
    Bodnar, Lubomir
    Smoter, Marta
    Szczylik, Cezary
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (04): : 253 - 258
  • [24] COMBINATION CHEMOTHERAPY WITH MOPP IN CHILDREN WITH RECURRENT BRAIN TUMORS
    CANGIR, A
    VANEYS, J
    BERRY, DH
    HVIZDALA, E
    MORGAN, SK
    MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 4 (03): : 253 - 261
  • [25] Salvage Chemotherapy for Refractory Germ Cell Tumors
    Dorff, Tanya B.
    Hu, James S.
    Quinn, David I.
    ONCOLOGY-NEW YORK, 2014, 28 (06): : 498 - 500
  • [26] Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors
    Minichmayr, Iris K.
    Knaack, Ursula
    Gojo, Johannes
    Senfter, Daniel
    Haberler, Christine
    Azizi, Amedeo A.
    Mayr, Lisa
    Zeitlinger, Markus
    Peyrl, Andreas
    PEDIATRIC DRUGS, 2024, 26 (04) : 429 - 440
  • [27] Three Cases of Recurrent or Refractory Medulloblastoma Treated with Bevacizumab, Irinotecan and Temozolomide
    Taniguchi, Maki
    Karakawa, Shuhei
    Shimomura, Maiko
    Kato, Yutaka
    Kawaguchi, Hiroshi
    Yamasaki, Fumiyuki
    Kobayashi, Masao
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S77 - S78
  • [28] SECONDARY SALVAGE INTRAVENOUS CHEMOTHERAPY FOR REFRACTORY/RECURRENT RETINOBLASTOMA
    Kaliki, Swathi
    Gavara, Suneetha
    Patil, Gaurav
    Palkonda, Vijay Anand Reddy
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (01): : 144 - 150
  • [29] Compassionate use of bevacizumab (Avastin®) in children and young adults with refractory or recurrent solid tumors
    Benesch, M.
    Windelberg, M.
    Sauseng, W.
    Witt, V.
    Fleischhack, G.
    Lackner, H.
    Gadner, H.
    Bode, U.
    Urban, C.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 807 - 813
  • [30] Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
    Bokstein, Felix
    Shpigel, Shulim
    Blumenthal, Deborah T.
    CANCER, 2008, 112 (10) : 2267 - 2273
12345